ID: h-var-1a318725cd
Hypothesis

Real-time closed-loop transcranial focused ultrasound targeting PVALB interneurons with continuous gamma oscillation feedback monitoring for precision neuromodulation in Alzheimer's disease

Real-time closed-loop transcranial focused ultrasound targeting PVALB interneurons with continuous gamma oscillation feedback monitoring for precision neuromodulation in Alzheimer's disease starts from the claim that modulating PVALB wit.
🧬 PVALB🩺 alzheimers🎯 Composite 56%💱 $0.57▲1.2%promoted
neuroscience
EvidenceStrong (66%)📖 65 cit🗣 2 debates 3 support 13 oppose
✓ All Quality Gates Passed
Mechanistic 0.91 (15%) Evidence 0.71 (15%) Novelty 0.50 (12%) Feasibility 0.56 (12%) Impact 0.73 (12%) Druggability 0.35 (10%) Safety 0.62 (8%) Competition 0.45 (6%) Data Avail. 0.80 (5%) Reproducible 0.95 (5%) KG Connect 0.72 (8%) 0.559 composite

🧪 Overview

Mechanistic Overview


Real-time closed-loop transcranial focused ultrasound targeting PVALB interneurons with continuous gamma oscillation feedback monitoring for precision neuromodulation in Alzheimer's disease starts from the claim that modulating PVALB within the disease context of Alzheimer's disease can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview Real-time closed-loop transcranial focused ultrasound targeting PVALB interneurons with continuous gamma oscillation feedback monitoring for precision neuromodulation in Alzheimer's disease starts from the claim that modulating PVALB within the disease context of Alzheimer's disease can redirect a disease-relevant process. The original description reads: "This hypothesis proposes a precision neuromodulation system that combines transcranial focused ultrasound (tFUS) targeting of CA1 parvalbumin-positive (PV) interneurons with real-time electroencephalography feedback to restore gamma oscillations in Alzheimer's disease.

...

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

graph TD
    SST["SST gene<br/>somatostatin interneurons"] --> PV["PV+ interneurons<br/>parvalbumin positive"]
    PV --> GAMMA_GEN["Gamma oscillation<br/>generation 40Hz"]
    GAMMA_GEN --> HIPP_SYNC["Hippocampal<br/>gamma rhythm"]
    GAMMA_GEN --> CORT_SYNC["Cortical<br/>gamma rhythm"]
    
    AMYLOID["Amyloid beta<br/>accumulation"] --> GAMMA_RED["Reduced gamma power<br/>40-70% decrease"]
    TAU["Tau pathology<br/>neurofibrillary tangles"] --> GAMMA_RED
    
    GAMMA_RED --> DESYNC["Hippocampal-cortical<br/>desynchronization"]
    DESYNC --> MEM_IMP["Memory impairment<br/>encoding and retrieval"]
    
    GET["Gamma entrainment<br/>therapy 40Hz"] --> GAMMA_REST["Gamma rhythm<br/>restoration"]
    GAMMA_REST --> SYNC_REC["Synchrony recovery<br/>between regions"]
    SYNC_REC --> MEM_IMPROVE["Memory function<br/>improvement"]
    
    HIPP_SYNC --> SYNC_NORM["Normal hippocampal-<br/>cortical synchrony"]
    CORT_SYNC --> SYNC_NORM
    SYNC_NORM --> MEM_NORM["Normal memory<br/>function"]

    style SST fill:#ce93d8,color:#0d0d1a
    style PV fill:#4fc3f7,color:#0d0d1a
    style GAMMA_GEN fill:#4fc3f7,color:#0d0d1a
    style HIPP_SYNC fill:#4fc3f7,color:#0d0d1a
    style CORT_SYNC fill:#4fc3f7,color:#0d0d1a
    style SYNC_NORM fill:#4fc3f7,color:#0d0d1a
    style MEM_NORM fill:#4fc3f7,color:#0d0d1a
    style AMYLOID fill:#ef5350,color:#0d0d1a
    style TAU fill:#ef5350,color:#0d0d1a
    style GAMMA_RED fill:#ef5350,color:#0d0d1a
    style DESYNC fill:#ef5350,color:#0d0d1a
    style MEM_IMP fill:#ef5350,color:#0d0d1a
    style GET fill:#81c784,color:#0d0d1a
    style GAMMA_REST fill:#81c784,color:#0d0d1a
    style SYNC_REC fill:#ffd54f,color:#0d0d1a
    style MEM_IMPROVE fill:#ffd54f,color:#0d0d1a

⚖️ Evidence

⚖️ Evidence Matrix3 supports13 contradicts
Supports
Brain connectivity and transcriptional changes induced by rTMS in first-episode major depressive disorder.
Transl Psychiatry2025PMID:40274783
Supports
Parvalbumin expression changes with retinal ganglion cell degeneration.
Front Neurosci2023PMID:37901418
Supports
Single-cell RNA sequencing of adult primate neocortex reveals the regulatory dynamics of neural plasticity.
Am J Transl Res2025PMID:40385068
Contradicts
Translation to human studies has shown mixed results with small effect sizes
Tremor Other Hyperkinet Mov (N Y)2022PMID:36211804medium
Abstract
BACKGROUND: Tremor is one of the most prevalent symptoms in Parkinson's Disease (PD). The progression and management of tremor in PD can be challenging, as response to dopaminergic agents might be relatively poor, particularly in patients with tremor-dominant PD compared to the akinetic/rigid subtype. In this review, we aim to highlight recent advances in the underlying pathogenesis and treatment modalities for tremor in PD. METHODS: A structured literature search through Embase was conducted using the terms "Parkinson's Disease" AND "tremor" OR "etiology" OR "management" OR "drug resistance" OR "therapy" OR "rehabilitation" OR "surgery." After initial screening, eligible articles were selected with a focus on published literature in the last 10 years. DISCUSSION: The underlying pathophysiology of tremor in PD remains complex and incompletely understood. Neurodegeneration of dopaminergic neurons in the retrorubral area, in addition to high-power neural oscillations in the cerebello-tha
Contradicts
Optimal stimulation parameters remain unclear across different AD stages
Hum Brain Mapp2017PMID:28714589medium
Abstract
Magnetoencephalography (MEG), a direct measure of neuronal activity, is an underexplored tool in the search for biomarkers of Alzheimer's disease (AD). In this study, we used MEG source estimates of auditory gating generators, nonlinear correlations with neuropsychological results, and multivariate analyses to examine the sensitivity and specificity of gating topology modulation to detect AD. Our results demonstrated the use of MEG localization of a medial prefrontal (mPFC) gating generator as a discrete (binary) detector of AD at the individual level and resulted in recategorizing the participant categories in: (1) controls with mPFC generator localized in response to both the standard and deviant tones; (2) a possible preclinical stage of AD participants (a lower functioning group of controls) in which mPFC activation was localized to the deviant tone only; and (3) symptomatic AD in which mPFC activation was not localized to either the deviant or standard tones. This approach showed
Contradicts
Gamma oscillation deficits in AD may reflect network damage rather than a treatable cause, questioning the therapeutic premise
Neuron2019PMID:30936556medium
Abstract
Despite expanding knowledge regarding the role of astroglia in regulating neuronal function, little is known about regional or functional subgroups of brain astroglia and how they may interact with neurons. We use an astroglia-specific promoter fragment in transgenic mice to identify an anatomically defined subset of adult gray matter astroglia. Using transcriptomic and histological analyses, we generate a combinatorial profile for the in vivo identification and characterization of this astroglia subpopulation. These astroglia are enriched in mouse cortical layer V; express distinct molecular markers, including Norrin and leucine-rich repeat-containing G-protein-coupled receptor 6 (LGR6), with corresponding layer-specific neuronal ligands; are found in the human cortex; and modulate neuronal activity. Astrocytic Norrin appears to regulate dendrites and spines; its loss, as occurring in Norrie disease, contributes to cortical dendritic spine loss. These studies provide evidence that hum
Contradicts
Sensory gamma entrainment shows rapid habituation with diminished neural response after 2 weeks of daily stimulation
NeuroImage2021PMID:33127896medium
Abstract
Mechanical anisotropy is an essential property for many biomolecules to assume their structures, functions and applications, however, the mechanisms for their direction-dependent mechanical responses remain elusive. Herein, by using a single-molecule nanopore sensing technique, we explore the mechanisms of directional mechanical stability of the xrRNA1 RNA from ZIKA virus (ZIKV), which forms a complex ring-like architecture. We reveal extreme mechanical anisotropy in ZIKV xrRNA1 which highly depends on Mg2+ and the key tertiary interactions. The absence of Mg2+ and disruption of the key tertiary interactions strongly affect the structural integrity and attenuate mechanical anisotropy. The significance of ring structures in RNA mechanical anisotropy is further supported by steered molecular dynamics simulations in combination with force distribution analysis. We anticipate the ring structures can be used as key elements to build RNA-based nanostructures with controllable mechanical anis
Contradicts
Translation of mouse gamma entrainment to humans is limited by skull attenuation and cortical folding differences
eLife2022PMID:34982715medium
Abstract
BACKGROUND: Gamification refers to the use of game elements in nongame contexts. The use of gamification to change behaviors and promote physical activity (PA) is a promising avenue for tackling the global physical inactivity pandemic and the current prevalence of chronic diseases. However, there is no evidence of the effectiveness of gamified interventions with the existence of mixed results in the literature. OBJECTIVE: The aim of this systematic review and meta-analysis is to evaluate the effectiveness of gamified interventions and their health care potential by testing the generalizability and sustainability of their influence on PA and sedentary behavior. METHODS: A total of 5 electronic databases (PubMed, Embase, Scopus, Web of Science, and the Cochrane Central Register of Controlled Trials) were searched for randomized controlled trials published in English from 2010 to 2020. Eligibility criteria were based on the components of the participants, interventions, comparators, and o
Contradicts
Epileptiform activity risk increases with prolonged 40 Hz stimulation in individuals with subclinical seizure susceptibility
Brain2023PMID:36478201high
Abstract
BACKGROUND: Nettle is a medicinal plant rich in bioactive molecules. The composition of nettle leaves and stems has been extensively studied, whereas the root has been insufficiently investigated. Therefore, the present study aimed to optimize the parameters of advanced extraction technique, pressurized liquid extraction (PLE), for the lipid fraction of nettle root rich in triterpenoid derivatives and to compare the efficiency of isolation under optimal conditions with conventional Soxhlet extraction (SE). RESULTS: The PLE yields ranged from 0.39-1.63%, whereas the total content of triterpenoid derivatives ranged from 43.50-78.26 mg 100 g-1 , with nine sterols and three pentacyclic triterpenoids identified and quantified within a total range of 42.81-76.57 mg 100 g-1 and 0.69-1.68 mg 100 g-1 dried root, respectively. The most abundant sterol and pentacyclic triterpenoid were β-sitosterol and β-amyrin acetate, with mean values of 50.21 mg 100 g-1 and 0.56 mg 100 g-1 dried root. CONCLUSI
Contradicts
Multi-site replication study finds variable gamma entrainment efficiency across AD patients, with APOE4 carriers showing reduced response
Ann Neurol2024PMID:38102334medium
Abstract
Despite the promising antitumor activity of SHP2 inhibitors in RAS-dependent tumours, overall responses have been limited by their narrow therapeutic window. Like with all MAPK pathway inhibitors, this is likely the result of compensatory pathway activation mechanisms. However, the underlying mechanisms of resistance to SHP2 inhibition remain unknown. The E3 ligase SMURF2 limits TGFβ activity by ubiquitinating and targeting the TGFβ receptor for proteosome degradation. Using a functional RNAi screen targeting all known phosphatases, we identify that the tyrosine phosphatase SHP2 is a critical regulator of TGFβ activity. Specifically, SHP2 dephosphorylates two key residues on SMURF2, resulting in activation of the enzyme. Conversely, SHP2 depletion maintains SMURF2 in an inactive state, resulting in the maintenance of TGFβ activity. Furthermore, we demonstrate that depleting SHP2 has significant implications on TGFβ-mediated migration, senescence, and cell survival. These effects can be
Contradicts
Somatostatin, Olfaction, and Neurodegeneration.
Front Neurosci2020PMID:32140092medium
Abstract
Alzheimer's and Parkinson's diseases are the most prevalent neurodegenerative disorders in aging. Hyposmia has been described as an early symptom that can precede cognitive and motor deficits by decades. Certain regions within the olfactory system, such as the anterior olfactory nucleus, display the neuropathological markers tau and amyloid-β or α-synuclein from the earliest stages of disease progression in a preferential manner. Specific neuronal subpopulations, namely those expressing somatostatin (SST), are preferentially affected throughout the olfactory and limbic systems. SST is a neuropeptide present in a subpopulation of GABAergic interneurons throughout the brain and its main function is to inhibit principal neurons and/or other interneurons. It has been reported that SST expression is reduced by 50% in Alzheimer's disease and that it is related to the formation of Aβ oligomers. The mechanisms underlying the preferential vulnerability of SST-expressing neurons in Alzheimer's d
Contradicts
Somatostatin and the pathophysiology of Alzheimer's disease.
Ageing Res Rev2024PMID:38484981medium
Abstract
Among the central features of Alzheimer's disease (AD) progression are altered levels of the neuropeptide somatostatin (SST), and the colocalisation of SST-positive interneurons (SST-INs) with amyloid-β plaques, leading to cell death. In this theoretical review, I propose a molecular model for the pathogenesis of AD based on SST-IN hypofunction and hyperactivity. Namely, hypofunctional and hyperactive SST-INs struggle to control hyperactivity in medial regions in early stages, leading to axonal Aβ production through excessive presynaptic GABAB inhibition, GABAB1a/APP complex downregulation and internalisation. Concomitantly, excessive SST-14 release accumulates near SST-INs in the form of amyloids, which bind to Aβ to form toxic mixed oligomers. This leads to differential SST-IN death through excitotoxicity, further disinhibition, SST deficits, and increased Aβ release, fibrillation and plaque formation. Aβ plaques, hyperactive networks and SST-IN distributions thereby tightly overlap
Contradicts
Functional Amyloids and their Possible Influence on Alzheimer Disease.
Discoveries (Craiova)2017PMID:32309597medium
Abstract
Amyloids play critical roles in human diseases but have increasingly been recognized to also exist naturally. Shared physicochemical characteristics of amyloids and of their smaller oligomeric building blocks offer the prospect of molecular interactions and crosstalk amongst these assemblies, including the propensity to mutually influence aggregation. A case in point might be the recent discovery of an interaction between the amyloid β peptide (Aβ) and somatostatin (SST). Whereas Aβ is best known for its role in Alzheimer disease (AD) as the main constituent of amyloid plaques, SST is intermittently stored in amyloid-form in dense core granules before its regulated release into the synaptic cleft. This review was written to introduce to readers a large body of literature that surrounds these two peptides. After introducing general concepts and recent progress related to our understanding of amyloids and their aggregation, the review focuses separately on the biogenesis and interactions
Contradicts
Therapeutic Potential of Somatostatin and Its Analogues in Alzheimer's Disease: From Molecular Mechanisms to Preclinical Studies.
Mol Neurobiol2026PMID:41854733medium
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder with limited treatment options. Currently approved agents, such as acetylcholinesterase inhibitors and NMDA receptor antagonists, provide only modest symptomatic benefit without modifying disease progression. Increasing evidence highlights the somatostatin (SST) system and its analogues (SSAs) as potential multitarget therapies. Somatostatin receptors (SSTR1-5) are widely expressed in cognition-related brain regions and participate in amyloid-β metabolism, tau phosphorylation, neuroinflammation, and synaptic plasticity. Preclinical studies suggest that SSAs enhance amyloid clearance via neprilysin activation, attenuate tau pathology through PI3K/Akt signaling, regulate APOE4 expression, and modulate microglial function, thereby protecting synaptic integrity. Compared with current monotherapies, SSAs may provide broader therapeutic benefits, particularly if applied in prodromal or early stages of AD. Advances in delive
Contradicts
From stress to Alzheimer's: A circuit-based framework for prefrontal cognitive dysfunction.
Neurosci Lett2025PMID:41115499medium
Abstract
Impairments in working memory and cognitive flexibility are early and consistent features of both Alzheimer's disease (AD) and stress. These functions depend critically on prefrontal cortical (PFC) circuits, which are particularly vulnerable to neuromodulatory and pathological insults. Recent studies suggest that stress and AD do not simply act globally, but instead converge on specific molecular and cellular targets within distinct neural populations. Notably, both chronic stress and Alzheimer's disease models exhibit dysregulation of synaptic signaling via NR2B-containing NMDA receptors and aberrant GSK-3β activation. These changes often emerge in a cell-type-specific manner, affecting excitatory pyramidal neurons and vulnerable interneuron subtypes such as SST+, PV+, and VIP + cells. The resulting imbalance in excitation and inhibition disrupts the integrity of prefrontal circuits, impairing adaptive behavior. This review synthesizes evidence across molecular, cellular, and circuit
Contradicts
Hippocampal Interneurons Shape Spatial Coding Alterations in Neurological Disorders.
Mol Neurobiol2025PMID:40392508medium
Abstract
Hippocampal interneurons (INs) play a fundamental role in regulating neural oscillations, modulating excitatory circuits, and shaping spatial representation. While historically overshadowed by excitatory pyramidal cells in spatial coding research, recent advances have demonstrated that inhibitory INs not only coordinate network dynamics but also contribute directly to spatial information processing. This review aims to provide a novel integrative perspective on how distinct IN subtypes participate in spatial coding and how their dysfunction contributes to cognitive deficits in neurological disorders such as epilepsy, Alzheimer's disease (AD), traumatic brain injury (TBI), and cerebral hypoxia-ischemia. We synthesize recent findings demonstrating that different IN classes-including parvalbumin (PV)-, somatostatin (SST)-, cholecystokinin (CCK)-, and calretinin (CR)-expressing neurons-exhibit spatially selective activity, challenging traditional views of spatial representation, and influe
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — PVALB

🧬 PDB 1B8C Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for PVALB from GTEx v10.

Cerebellum627 Cerebellar Hemisphere435 Frontal Cortex BA966.7 Cortex36.0 Spinal cord cervical c-123.1 Substantia nigra22.3 Anterior cingulate cortex BA2414.6 Hippocampus4.4 Putamen basal ganglia3.4 Hypothalamus1.3 Amygdala1.1 Caudate basal ganglia1.1 Nucleus accumbens basal ganglia0.6median TPM (GTEx v10)

💉 Clinical Trials (3)Relevance: 73%

0
Active
0
Completed
270
Total Enrolled
PHASE1
Highest Phase
NOT_YET_RECRUITING·NCT07241598 · Mahidol University
70 enrolled · 2025-12-01 · → 2027-12-01
As the global population ages, the prevalence of mild cognitive impairment (MCI) among older adults, which ranges from 5% to 40%, is expected to rise. MCI significantly increases the risk of developin
Mild Cognitive Impairment (MCI)
Smart±step cognitive-motor training
RECRUITING·NCT06206824 · Perha Pharmaceuticals
164 enrolled · 2024-01-18 · → 2026-06
Leucettinib-21 First-in-Human Phase 1 Study in 6 Parts: Single (Part 1 and 5) and Multiple (Part 3 and 6) Ascending Doses, and Food-Effect (Part 2) in Healthy Subjects, and Single Dose (Part 4) in Peo
Healthy Volunteers Down Syndrome Alzheimer's Disease
Leucettinib-21
UNKNOWN·NCT05663918 · McMaster University
36 enrolled · 2023-02-13 · → 2025-01-01
The research is focused on ameliorating cognitive decline in aging and in individuals diagnosed with Mild Cognitive Impairment (MCI). In the proposed research, we ask whether synaptic plasticity is mo
Mild Cognitive Impairment
Self- determined Intensity Interval Training

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for PVALB →

No DepMap CRISPR Chronos data found for PVALB.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline
4.5 years

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0114
Events (7d)
1
Price History
▲1.2%

💾 Resource Usage

LLM Tokens
18,988
$0.1139
Total Cost
$0.1139

📖 References (11)

  1. Gamma Entrainment Binds Higher-Order Brain Regions and Offers Neuroprotection.
    ["Adaikkan C" et al.. Neuron (2019)
  2. Acute stress promotes brain oscillations and hippocampal-cortical dialog in emotional processing.
    ["Lv X" et al.. Biochemical and biophysical research communications (2022)
  3. The influenza-injured lung microenvironment promotes MRSA virulence, contributing to severe secondary bacterial pneumonia.
    ["Langou\u00ebt-Astri\u00e9 C" et al.. Cell reports (2022)
  4. Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1.
    Zhang T et al.. Science (2023)
  5. Complement C1q/C3-CR3 signaling pathway mediates abnormal microglial phagocytosis of synapses in a mouse model of depression.
    Han QQ et al.. Brain Behav Immun (2024)
  6. The cholesterol 24-hydroxylase CYP46A1 promotes α-synuclein pathology in Parkinson's disease.
    Dai L et al.. PLoS biology (2025)
  7. Tremor in Parkinson's Disease: From Pathophysiology to Advanced Therapies.
    ["Abusrair A" et al.. Tremor and other hyperkinetic movements (New York, N.Y.) (2022)
  8. MEG biomarker of Alzheimer's disease: Absence of a prefrontal generator during auditory sensory gating.
    ["Josef Golubic S" et al.. Human brain mapping (2017)
  9. Molecularly defined cortical astroglia subpopulation modulates neurons via secretion of Norrin.
    ["Miller S" et al.. Nature neuroscience (2019)
  10. Molecular mechanisms underlying the extreme mechanical anisotropy of the flaviviral exoribonuclease-resistant RNAs (xrRNAs).
    ["Niu X" et al.. Nature communications (2020)
  11. Evaluating the Effectiveness of Gamification on Physical Activity: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    ["Mazeas A" et al.. Journal of medical Internet research (2022)
Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
sourcev1_phase_c_backfill
origin_typegap_debate
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.